IP Verse

Mylan Pharmaceuticals Inc. et al. vs Allergan, Inc.

The detailed information for PTAB case with proceeding number IPR2016-01132 filed by Mylan Pharmaceuticals Inc. et al. against Allergan, Inc. on Jun 3, 2016. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2016-01132
Filing Date
Jun 3, 2016
Petitioner
Mylan Pharmaceuticals Inc. et al.
Respondent
Allergan, Inc.
Status
Terminated
Respondent Application Number
14222478
Respondent Tech Center
1600
Respondent Patent Number
9248191
Institution Decision Date
Dec 8, 2016
Termination Date
Sep 27, 2019

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Termination Dismissed After Institution

Sep 27, 2019PAPERBOARD

Petitioner Mylan Pharmaceuticals Inc.'s Mandatory Change-of-Information Notices

Jun 7, 2019PAPERPETITIONER

Petitioner Mylan Pharmaceuticals Inc.'s Mandatory Change-of-Information Notices

May 3, 2019PAPERPETITIONER

Mylan Pharmaceuticals Inc.'s Mandatory Change-of-Information Notices

Apr 15, 2019PAPERPETITIONER

Mylan's CORRECTED Motion for PHV Admission

Feb 28, 2019PAPERPETITIONER

Petitioner Mylan Pharmaceuticals Inc.'s Mandatory Change-of-Information Notices

Feb 27, 2019PAPERPETITIONER

Canceling Oral Argument

Jan 7, 2019PAPERBOARD

Petitioner Mylan Pharmaceuticals Inc.'s Mandatory Change-of-Information Notices

Jan 7, 2019PAPERPETITIONER

Petitioners' Update Exhibit List

Jan 2, 2019PAPERPETITIONER

Exhibit 1174 - Dec. 13, 2018 Conference Call

Jan 2, 2019EXHIBITPETITIONER

Akorn's Updated Mandatory Notices

Dec 27, 2018PAPERPETITIONER

Teva Pharmaceuticals USA, Inc.'s Updated Mandatory Notices

Dec 26, 2018PAPERPETITIONER

Teva Pharmaceuticals USA, Inc.'s Updated Power of Attorney

Dec 26, 2018PAPERPETITIONER

Patent Owner's Supplemental Briefing on Collateral Estopel

Dec 21, 2018PAPERPATENT OWNER

Allergan's Brief on Representative Claims

Dec 21, 2018EXHIBITPATENT OWNER

Docket from CRESPE LLC v. Silicon Laboratories Inc

Dec 21, 2018EXHIBITPATENT OWNER

January 26, 2017 Memorandum Opinion and Order regarding reduction of asserted claims

Dec 21, 2018EXHIBITPATENT OWNER

ORDER - Denying Request for Authorization to File Motion to Stay 37 C.F.R ¿¿ 42.5

Dec 20, 2018PAPERBOARD

Exhibit 3005.

Dec 20, 2018EXHIBITBOARD

Petitioners Supplemental Briefing

Dec 14, 2018PAPERPETITIONER

Exhibit 1173 - Pretrial Conference Hearing Transcript

Dec 14, 2018EXHIBITPETITIONER

Rescheduling the Date for Oral Argument; Authorizing Supplemental Briefing 37 C.F.R. § 42.5

Nov 30, 2018PAPERBOARD

Exhibits 3004

Nov 30, 2018EXHIBITBOARD

Petitioner Mylan Pharmaceutical Inc.'s Mandatory Change-of-Information Notices

Nov 21, 2018PAPERPETITIONER

Petitioner's Updated Exhibit List

Nov 21, 2018PAPERPETITIONER

Rule 36 Judgment

Nov 21, 2018EXHIBITPETITIONER

Conduct of the Proceedings 37 C.F.R. sec 42.5

Mar 28, 2018PAPERBOARD

United States Court of Appeals for the Federal Circuit ______________________ SAINT REGIS MOHAWK TRIBE, ALLERGAN, INC., Appellants, v. MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA, INC., AKORN, INC.

Mar 28, 2018EXHIBITBOARD

Denying Patent Owners Motion Concerning Boards Divested Jurisdiction or, in the Alternative, for a Stay Pending the Appeal 37 C.F.R. sec 42.5

Mar 22, 2018PAPERBOARD

Rescheduling the Date for Oral Argument 37 C.F.R. sec 42.5

Mar 22, 2018PAPERBOARD

Peitioners' Opposition to Motion to Stay

Mar 14, 2018PAPERPETITIONER

EX1171 - HR098P1.PS - Excerpts

Mar 14, 2018EXHIBITPETITIONER

EX1169 - Federal Practice and Proc. - 3914.10 - Excerpts

Mar 14, 2018EXHIBITPETITIONER

EX1170 - Federal Practice and Proc. - 3914.18

Mar 14, 2018EXHIBITPETITIONER

JOINT MOTION BY PATENT OWNER SAINT REGIS MOHAWK TRIBE AND ALLERGAN CONCERNING BOARD¿¿¿S DIVESTED JURISDICTION OR, IN THE ALTERNATIVE, FOR A STAY PENDING THE APPEAL

Mar 8, 2018PAPERPATENT OWNER

Petitioners' Updated Exhibit List

Mar 8, 2018PAPERPETITIONER

Exhibit 1168 - Transcript of March 5, 2018 Call

Mar 8, 2018EXHIBITPETITIONER

Combined Notice of Appeal to the United States Court of Appeals for the Federal Circuit by Saint Regis Mohawk Tribe and Allergan, Inc.

Feb 28, 2018PAPERPATENT OWNER

Order Denying the Tribe Motion to Terminate

Feb 23, 2018PAPERBOARD

EXPUNGED

Feb 23, 2018PAPERBOARD

Conduct of the Proceeding

Feb 23, 2018PAPERBOARD

Petitioners' Opposition to Patent Owner's Motion to Withdraw

Jan 17, 2018PAPERPETITIONER

Patent Owner's Supplemental Brief on Litigation Waiver

Jan 12, 2018PAPERPATENT OWNER

Allergan Inc.'s Motion to Withdraw

Jan 9, 2018PAPERPATENT OWNER

Petitioners' Supplemental Brief on Litigation Waiver

Jan 5, 2018PAPERPETITIONER

Order Denying Request for Oral Hearing and Denying Renewed Request for Authorization to File Motion for Additional Discovery

Jan 4, 2018PAPERBOARD

Patent Owner's Updated Exhibit List

Jan 2, 2018PAPERPATENT OWNER

Patent Owner's Request for Oral Hearing

Jan 2, 2018PAPERPATENT OWNER

Emails concerning Discovery

Jan 2, 2018EXHIBITPATENT OWNER

Patent Owner's Response to Amicus Briefing

Dec 15, 2017PAPERPATENT OWNER

Michelle Stephenson, The Latest Uses for Restatis, Review of Opthalmology, Dec. 30, 2005

Dec 15, 2017EXHIBITPATENT OWNER

Eric Donnenfeld MD and Stephen Pflugfelder MD, Topical Ophthalmic Cyclosporine: Pharmacology and Clinical Uses, Survey of Ophthalmology, Vol 54, Number 3, May-June 2009

Dec 15, 2017EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Dec 15, 2017PAPERPATENT OWNER

Petitioners¿¿¿ Response After Amicus Briefing

Dec 15, 2017PAPERPETITIONER

Exhibit 1167 - Brief for the Federal Respondent

Dec 15, 2017EXHIBITPETITIONER

Amicus Curiae Brief of The BSA | The Software Alliance

Dec 4, 2017PAPERBOARD

Amicus Curiae Brief of James R. Major

Dec 4, 2017PAPERBOARD

Amicus Curiae Brief of Scholars

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of Askeladden LLC

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of Deva Holding A.S.

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of the SIIA

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of the High Tech Inventors Alliance

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of the Seneca Nation

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of the NAIPEC

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of U.S. Inventor, LLC

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of The National Congress of American Indians et al.

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of Luis Ortiz and Kermit Lopez

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of The Association for Accessible Medicines

Dec 1, 2017PAPERBOARD

Amicus Curiae Brief of the Oglala Siux Tribe

Nov 30, 2017PAPERBOARD

Amicus Curiae Brief of the Public Knowledge and the Electronic Frontier Foundation

Nov 30, 2017PAPERBOARD

Decision Granting Motions to Seal

Nov 29, 2017PAPERBOARD

Petitioners Notice of Objection to Evidence

Nov 27, 2017PAPERPETITIONER

Petitioners' Opposition to St. Regis Mohawk Tribe's Motions to Seal

Nov 22, 2017PAPERPETITIONER

Exhibit 1166 - October 11 2017 email chain

Nov 22, 2017EXHIBITPETITIONER

Excerpts of Chief Judge David Rushke at 11-09-17 PPAC Quarterly Meeting

Nov 17, 2017EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Nov 17, 2017PAPERPATENT OWNER

Patent Owner's Motion to Seal

Nov 16, 2017PAPERPATENT OWNER

Declaration of Dale White in Support of Patent Owner's Motion to Seal

Nov 16, 2017EXHIBITPATENT OWNER

REDACTED Exhibit 2086 Patent Assignment Agreement

Nov 16, 2017EXHIBITPATENT OWNER

REDACTED Exhibit 2087 Patent License Agreement

Nov 16, 2017EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Nov 16, 2017PAPERPATENT OWNER

Order Conduct of the Proceedings

Nov 9, 2017PAPERBOARD

Ex. 3002

Nov 6, 2017EXHIBITBOARD

Order Conduct of Proceeding

Nov 3, 2017PAPERBOARD

Petitioners Notice of Objection to Evidence

Oct 27, 2017PAPERPETITIONER

Ex. 2105 - IP and the US Economy Sept 2016

Oct 20, 2017EXHIBITPATENT OWNER

Patent Owner's Reply to Opposition To Motion to Dismiss for Lack of Jurisdiction Based on Tribal Sovereign Immunity

Oct 20, 2017PAPERPATENT OWNER

Ex. 2107 - GIPC IP Index 2017 Report

Oct 20, 2017EXHIBITPATENT OWNER

Ex. 2109 - 2017 SRMT Ltr to Grassley & Feinstein (Judiciary)

Oct 20, 2017EXHIBITPATENT OWNER

Ex. 2110 - Reverse Patent Trolling - Westlaw

Oct 20, 2017EXHIBITPATENT OWNER

Ex. 2106 - Guest Post - America Invents Act Cost the US Economy Over $1 Trillion - Patently-O

Oct 20, 2017EXHIBITPATENT OWNER

Ex. 2108 - PTAB's 'Death Squad' Label Not Totally Off-Base, Chief Says - Law360

Oct 20, 2017EXHIBITPATENT OWNER

Ex. 2111 - Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restaysis

Oct 20, 2017EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Oct 20, 2017PAPERPATENT OWNER

Patent Owner's Updated Mandatory Notices

Oct 18, 2017PAPERPATENT OWNER

Saint Regis Mohawk Tribe's Notice of Objection to Evidence

Oct 18, 2017PAPERPATENT OWNER

Petitioners¿¿¿ Updated Exhibit List

Oct 18, 2017PAPERPETITIONER

Exhibit 1164 - Findings of Fact and Conclusions of Law

Oct 18, 2017EXHIBITPETITIONER

Exhibit 1165 - Final Judgment

Oct 18, 2017EXHIBITPETITIONER

Exhibit 1163 - Memorandum and Order

Oct 18, 2017EXHIBITPETITIONER

Petitioner Mylan Pharmaceuticals Inc.'s Mandatory Change-of-Information Notices

Oct 17, 2017PAPERPETITIONER

Decision Granting Pro Hac Vice Admission of Marsha K. Schmidt

Oct 17, 2017PAPERBOARD

EX1144 NPR Radio

Oct 13, 2017EXHIBITPETITIONER

EX1145 SRMT FAQ

Oct 13, 2017EXHIBITPETITIONER

EX1150 Waxman Criticism

Oct 13, 2017EXHIBITPETITIONER

EX1151 Plantiffs Production of Documents

Oct 13, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - IPR2016-01127 et seq - Opposition to Motion to Terminate

Oct 13, 2017PAPERPETITIONER

REDACTED - IPR2016-01127 et seq - Opposition to Motion to Terminate

Oct 13, 2017PAPERPETITIONER

EX1146 IP Watchdog

Oct 13, 2017EXHIBITPETITIONER

EX1147 IamMedia

Oct 13, 2017EXHIBITPETITIONER

EX1148 Fox Business

Oct 13, 2017EXHIBITPETITIONER

EX1149 Health Care Alliances Letter

Oct 13, 2017EXHIBITPETITIONER

EX1152 AAM White Paper Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents

Oct 13, 2017EXHIBITPETITIONER

EX1153 Reuters

Oct 13, 2017EXHIBITPETITIONER

EX1162 Dine Citizens Against Ruining Our Environment v US Office of Surface Mining Recl

Oct 13, 2017EXHIBITPETITIONER

EX1154 Excerpted Allergan's Response to Motion for Summary Jugement

Oct 13, 2017EXHIBITPETITIONER

EX1155 Bloomberg News

Oct 13, 2017EXHIBITPETITIONER

EX1156 Federal Respondent Oil States

Oct 13, 2017EXHIBITPETITIONER

EX1157 SRMT News Update

Oct 13, 2017EXHIBITPETITIONER

EX1158 FlowRider Surf Ltd v Pacific Surf Designs Inc

Oct 13, 2017EXHIBITPETITIONER

EX1159 Gingras v Rosette

Oct 13, 2017EXHIBITPETITIONER

EX1160 Commonwealth of Pennsylvania v Think Finance Inc

Oct 13, 2017EXHIBITPETITIONER

EX1161 SourceOne Global Partners LLC v KGK Synergize Inc

Oct 13, 2017EXHIBITPETITIONER

Conduct of the Proceedings 37 C.F.R sec 42.5

Oct 4, 2017PAPERBOARD

Petitioners¿¿¿ Notice of Objection to Evidence

Sep 29, 2017PAPERPETITIONER

Petitioners' Updated Exhibit List

Sep 28, 2017PAPERPETITIONER

Exhibit 1143 - Transcript of September 26, 2017 Conference Call

Sep 28, 2017EXHIBITPETITIONER

Petitioner Mylan Pharma. Inc.'s Mandatory Change-Of-Information Notices

Sep 25, 2017PAPERPETITIONER

Patent Owner's Motion to Dismiss for Lack of Jurisdiction Based on Tribal Sovereign Immunity

Sep 22, 2017PAPERPATENT OWNER

TCR-2017-36

Sep 22, 2017EXHIBITPATENT OWNER

Reactive Surfaces Ltd., LLP v. Toyota Motor Corp., Case IPR2016-01914, Paper 36 (July 13, 2017)

Sep 22, 2017EXHIBITPATENT OWNER

Order, Allergan, Inc. v. Teva Pharmas USA, Inc. et al, No. 2:15-cv-1455 (E.D. Tex.), Docket No. 478 (September 8, 2017)

Sep 22, 2017EXHIBITPATENT OWNER

Joint Pre-Trial Order in Allergan, Inc. v. Teva Pharmaceuticals USA, Inc., et al., No. 2:15-cv-1455 (E.D. Tex.), Docket No. 379 (July 25, 2017)

Sep 22, 2017EXHIBITPATENT OWNER

National Congress of American Indians, Taxation

Sep 22, 2017EXHIBITPATENT OWNER

Declaration of Marsha K. Schmidt in Support of Motion for Pro Hac Vice Admission

Sep 22, 2017EXHIBITPATENT OWNER

Federal Register, Vol. 82, No. 10, January 17, 2017

Sep 22, 2017EXHIBITPATENT OWNER

Treaty with the Seven Nations of Canada, 1796

Sep 22, 2017EXHIBITPATENT OWNER

Executive Order 13647

Sep 22, 2017EXHIBITPATENT OWNER

Covidien LP v. Univ. of Fla. Research Found. Inc., Case IPR 2016-01274, Paper 21 (Jan. 25, 2017)

Sep 22, 2017EXHIBITPATENT OWNER

Neochord, Inc. v. Univ. of Md., et al, Case IPR2016-00208, Paper 28 (May 23, 2017)

Sep 22, 2017EXHIBITPATENT OWNER

National Congress of American Indians, Current Tax Needs in Indian Country

Sep 22, 2017EXHIBITPATENT OWNER

National Congress of American Indians, Securing Our Futures

Sep 22, 2017EXHIBITPATENT OWNER

Patent Assignment from Allergan, Inc. to Saint Regis Mohawk Tribe dated 09/08/17

Sep 22, 2017EXHIBITPATENT OWNER

Patent Owner's Motion for Pro Hac Vice Admission of Marsha K. Schmidt

Sep 22, 2017PAPERPATENT OWNER

Patent Owner's Updated Exhibit List

Sep 22, 2017PAPERPATENT OWNER

Declaration of Shannon M. Bloodworth

Sep 21, 2017EXHIBITPETITIONER

Declaration of Eric D. Miller

Sep 21, 2017EXHIBITPETITIONER

Mylan's Motion for Pro Hac Vice Admission of Attorneys Bloodworth, Curtis, MacLean, Miller, and Sharp

Sep 21, 2017PAPERPETITIONER

Petitioner's Updated Exhibit List

Sep 21, 2017PAPERPETITIONER

Declaration of Charles G. Curtis, Jr.

Sep 21, 2017EXHIBITPETITIONER

Declaration of Jennifer A. MacLean

Sep 21, 2017EXHIBITPETITIONER

Declaration of Benjamin S. Sharp

Sep 21, 2017EXHIBITPETITIONER

Petitioner Mylan Pharmaceuticals Inc. Mandatory Change-of-Information Notices

Sep 20, 2017PAPERPETITIONER

EXPUNGED

Sep 19, 2017PAPERBOARD

Granting Motion for Pro Hac Vice Admission of Christopher L. Evans 37 C.F.R. sec 42.10

Sep 19, 2017PAPERBOARD

Granting Motion for Pro Hac Vice Admission of Michael W. Shore 37 C.F.R. sec 42.10

Sep 19, 2017PAPERBOARD

Conduct of the Proceedings 37 C.F.R. sec. 42.5

Sep 19, 2017PAPERBOARD

09/11/17 Transcript of Telephonic Hearing Before PTAB

Sep 12, 2017EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Sep 12, 2017PAPERPATENT OWNER

Exhibit 1137 - Transcript of Conference Call on 9.11.17

Sep 12, 2017EXHIBITPETITIONER

Petitioners' Updated Exhibit List

Sep 12, 2017PAPERPETITIONER

Petitioner Mylan Pharmaceuticals Inc. Mandatory Change-of-Information Notices

Sep 11, 2017PAPERPETITIONER

Patent Owner's Motion for pro hac vice Admission of Christopher Evans

Sep 11, 2017PAPERPATENT OWNER

Patent Owner's Motion for pro hac vice Admission of Michael Shore

Sep 11, 2017PAPERPATENT OWNER

Declaration of Christopher Evans in support of Motion for pro hac vice Admission

Sep 11, 2017EXHIBITPATENT OWNER

Declaration of Michael Shore in support of Motion for pro hac vice Admission

Sep 11, 2017EXHIBITPATENT OWNER

Patent Owner's Updated Exhibit List

Sep 9, 2017PAPERPATENT OWNER

Patent Assignment Agreement

Sep 9, 2017EXHIBITPATENT OWNER

Patent License Agreement

Sep 9, 2017EXHIBITPATENT OWNER

Assignment

Sep 8, 2017EXHIBITPATENT OWNER

SRMT Power of Attorney

Sep 8, 2017PAPERPATENT OWNER

Updated Mandatory Notice

Sep 8, 2017PAPERPATENT OWNER

Petitioner Mylan Pharmaceuticals Inc.¿¿¿s Mandatory Change-of-Information Notices

Sep 6, 2017PAPERPETITIONER

Patent Owner's Exhibit List

Aug 16, 2017PAPERPATENT OWNER

REPLACEMENT - Deposition transcript of Andrew F. Calman, M.D., Ph.D. with Errata

Aug 16, 2017EXHIBITPATENT OWNER

REPLACEMENT - Deposition transcript of Daniel A. Bloch, Ph.D. with Errata

Aug 16, 2017EXHIBITPATENT OWNER

REPLACEMENT - Deposition transcript of Ivan T. Hofmann with Errata

Aug 16, 2017EXHIBITPATENT OWNER

Order - 37 C.F.R. 42.5

Aug 11, 2017PAPERBOARD

Patent Owner's Reply to Opposition to Motion to Exclude

Aug 3, 2017PAPERPATENT OWNER

Petitioners¿¿¿ Reply in Support of Petitioners¿¿¿ Motion to Exclude Evidence

Aug 3, 2017PAPERPETITIONER

Exhibit 1135 - July 6, 2017 Email

Aug 3, 2017EXHIBITPETITIONER

Exhibit 1136 - July 21, 2017 Email

Aug 3, 2017EXHIBITPETITIONER

Granting Request for Oral Argument

Aug 1, 2017PAPERBOARD

Patent Owner's Opposition to Petitioner's Motion to Exclude Evidence

Jul 27, 2017PAPERPATENT OWNER

Petitioners¿¿¿ Opposition to Patent Owner¿¿¿s Motion to Exclude Evidence

Jul 27, 2017PAPERPETITIONER

Petitioners¿¿¿ Response to Patent Owner¿¿¿s Motion for Observations on the Cross-Examination of Dr. Andrew Calman

Jul 27, 2017PAPERPETITIONER

Petitioners¿¿¿ Response to Patent Owner¿¿¿s Motion for Observations on the Cross-Examination of Dr. Daniel A. Bloch

Jul 27, 2017PAPERPETITIONER

Petitioners¿¿¿ Response to Patent Owner¿¿¿s Motion for Observations on the Cross-Examination of Testimony Mr. Ivan T. Hofmann

Jul 27, 2017PAPERPETITIONER

Patent Owner's Motion to Exclude Evidence

Jul 20, 2017PAPERPATENT OWNER

Patent Owner's Motion for Observations of Andrew F. Calman, M.D., Ph.D.

Jul 20, 2017PAPERPATENT OWNER

Patent Owner's Motion for Observations of Daniel A. Bloch, Ph.D.

Jul 20, 2017PAPERPATENT OWNER

Patent Owner's Motion for Observations of Ivan T. Hofmann

Jul 20, 2017PAPERPATENT OWNER

Deposition transcript of Andrew F. Calman, M.D., Ph.D.

Jul 20, 2017EXHIBITPATENT OWNER

Deposition transcript of Daniel A. Bloch, Ph.D.

Jul 20, 2017EXHIBITPATENT OWNER

Deposition transcript of Ivan T. Hofmann

Jul 20, 2017EXHIBITPATENT OWNER

Patent Owner¿¿¿s Request for Oral Hearing

Jul 20, 2017PAPERPATENT OWNER

Petitioners' Request for Oral Argument

Jul 20, 2017PAPERPETITIONER

Petitioners' Notice of Objection to Evidence

Jul 20, 2017PAPERPETITIONER

Petitioners' Motion to Exclude Evidence

Jul 20, 2017PAPERPETITIONER

Exhibit 1134 - June 5, 2017 Email

Jul 20, 2017EXHIBITPETITIONER

Medical Officer's Review of NDA 21-023

Jul 14, 2017EXHIBITPATENT OWNER

Correction to Sall article (Ex. 1007)

Jul 14, 2017EXHIBITPATENT OWNER

GraphPad Calculation of Bloch Table 2 - 3 mo. C vs A.

Jul 14, 2017EXHIBITPATENT OWNER

Patent Owner's Surreply

Jul 14, 2017PAPERPATENT OWNER

Nussenblatt, R. et al. Local Cyclosporine Therapy for Experimental Autoimmune Uveitis in Rats.

Jul 14, 2017EXHIBITPATENT OWNER

GraphPad Calculation of Bloch Table 2 - 3 mo. B vs A.

Jul 14, 2017EXHIBITPATENT OWNER

Granting Pro Hac Vice Admission

Jul 13, 2017PAPERBOARD

Patent Owner's Objections to Evidence

Jul 10, 2017PAPERPATENT OWNER

Petitioner Mylan Pharmaceuticals Inc.'s Motion for Pro Hac Vice Admission

Jul 7, 2017PAPERPETITIONER

Exhibit 1133 - Declaration of Anna G. Phillips ISO Petitioner Mylan Pharmaceuticals Inc.'s Motion for Pro Hac Vice Admission

Jul 7, 2017EXHIBITPETITIONER

Patent Owner's Notice of Deposition of Andrew F. Calman, M.D., Ph.D.

Jul 5, 2017PAPERPATENT OWNER

Patent Owner's Notice of Deposition of Daniel A. Bloch, Ph.D.

Jul 5, 2017PAPERPATENT OWNER

Patent Owner's Notice of Deposition of Ivan T. Hofmann

Jul 5, 2017PAPERPATENT OWNER

Exhibit 1027 - Allergan Report No. PK-00-163 - 2000 PK Study

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1028 - Allergan Notebook Number L-2000-7626

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1029 - Allergan Notebook Number L-1998-5709 - Part 1 of 3

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1029 - Allergan Notebook Number L-1998-5709 - Part 3 of 3

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1029 - Allergan Notebook Number L-1998-5709 - Part 2 of 3

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1030 - Allergan Notebook Number L-1998-5707 - Part 1 of 2

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1030 - Allergan Notebook Number L-1998-5707 - Part 2 of 2

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1032 - Orange Book 29th Eddition (2009)

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1034 - Maness Deposition Transcript

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1035 - Schiffman Deposition Transcript

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1031 - Allergan Notebook Number L-2000-7726 - Part 1 of 2

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1031 - Allergan Notebook Number L-2000-7726 - Part 2 of 2

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1033 - Mayssa Attar Professional Linkedin Profile

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1036 - Loftsson Deposition Transcript with Errata Sheet

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1037 - Sheppard Deposition Transcript

Jun 30, 2017EXHIBITPETITIONER

REDACTED - Exhibit 1038 - Attar Deposition Transcript

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1045 - Facts About Dry Eye

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1038 - Attar Deposition Transcript

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1046 - Niederkorn et al

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1048 - Garralt (2011)

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1047 - Garralt (2013)

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1049 - Stanford News

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1052 - Marsh et al

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1054 - Eadie et al

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1055 - Gaulhofer

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1056 - Rolando et al

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1050 - Allergan Release

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1051 - Neurostimulator News

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1053 - Sainz et al. Abstract

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1057 - Glenn

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1058 - Oellerich et al

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1060 - Avunduk

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1059 - Foulks et al. 2007 DEWS dry eye study report

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1061 - Lamberts

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1062 - Akpek et al

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1063 - Allergan Inc. 2015 10-K

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1065 - Allergan Inc. 2009 10-K

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1068 - Allergan Inc. 1993 10-K

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1071 - Restasis - Chronic Dry Eye Disease

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1064 - NDA 050790

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1066 - Allergan PR Restasis MultiDose

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1067 - Restasis MultiDose Label 10.2016

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1069 - Orange Book_ Restasis

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1070 - Kymionis et al. - NCBI Treatment of Chronic Dry Eye

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1073 - Merck Manuals KCS

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1075 - Javadi et al. - NCBI Dry Eye Syndrome

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1072 - Allergan Inc. 2002 10-K

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1074 - Abelson et al. - A Stepwise Approach

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1078 - Bailey - Opt Times Shire

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1079 - Mayo Clinic Dry Eyes

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1076 - Xiidra

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1077 - FDA News Release Xiidra

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1080 - Scleral Lenses

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1081 - Jedlicka - scleral-lenses

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1084 - Lacrisert FDA Label

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1085 - Stephenson - otc-drops-telling

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1086 - Narayanan - which-drop-for-dry-eye

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1082 - Merck v. Teva 395 F.3d 1364

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1083 - Seeking Alpha Allergan

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1087 - Schachet - the-golden-age-of-dry-eye

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1088 - Refresh Products

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1089 - Bausch Alrex

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1093 - methylprednisolone-

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1094 - Hessen et al. - NCBI DE Inflam Ocular Disease

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1095 - E Medicine Health - What is Dry Eye Syndrome

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1097 - Adler - AllAboutVision Dry Eye

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1098 - Ramsey - Business Insider allergan-history

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1100 - Allergan Q3 2016 Earnings Call

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1090 - Bausch Lotemax

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1091 - mednet fluorometholone-oph

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1092 - mednet rimexolone

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1096 - Mrukwa-Kominek et al. - NCBI Effect of Anti-Inflamm Therapy

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1099 - www.allerganoptometry.com Product Information

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1104 - Allergan Q3 2015 Earnings Call

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1105 - Allergan Q3 2013 Earnings Call

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1101 - Allergan Q2 2016 Earnings Call

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1102 - Allergan Inc. 2005 10-K

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1103 - Allergan Inc. 2014 10-K

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1106 - Allergan Q4 2007 Earnings Call

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1107 - Allergan Q1 2009 Earnings Call

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1108 - Allergan Q3 2009 Earnings Call

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1111 - actress-marisa tomei

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1112 - Allergan Inc. 2011 10-K

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1113 - Bihari - understanding-formulary

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1114 - BCBS Copayment Tiers

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1117 - Restasis TermsAndConditions5

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1109 - Weintraub - Allergan Smoothing the Wrinkles

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1110 - Restasis commercial among most memorable ads of 2013

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1115 - Allergan Q4 2015 Earnings Transcript

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1116 - Restasis Program-Benefits

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1123 - AGN_RES1120941

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1126 - AGN_RES1124168

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1127 - AGN_RES1134471

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1129 - AGN_RES1147652

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1131 - AGN_RES1153653

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1118 - Ivan T Hofmann List of Testimony

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1119 - AGN_RES1123159

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1120 - AGN_RES1147478

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1121 - AGN_RES0614120

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1124 - AGN_RES1148612

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1125 - AGN_RES0734285

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1128 - AGN_RES1146945

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1130 - AGN_RES1154033

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1039 - Declaration of Andrew Calman

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1044 - Hofmann CV

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1040 - Declaration of Daniel A. Bloch

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - Exhibit 1041 - Declaration of Ivan Hofmann

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1042 - Calman CV

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1043 - Bloch CV

Jun 30, 2017EXHIBITPETITIONER

Exhibit 1132 - Schuurhuis, G.J. et al

Jun 30, 2017EXHIBITPETITIONER

PROTECTIVE ORDER MATERIAL - 2017.06.30 - Petitioners' Reply

Jun 30, 2017PAPERPETITIONER

2017.06.30 - Petitioners' Motion to Seal

Jun 30, 2017PAPERPETITIONER

Conduct of the Proceedings

Jun 12, 2017PAPERBOARD

Petitioner¿¿¿s Notice of Deposition of John D. Sheppard, M.D., M.M.Sc

Jun 5, 2017PAPERPETITIONER

Petitioner¿¿¿s Notice of Deposition of Mayssa Attar, Ph.D

Jun 5, 2017PAPERPETITIONER

Granting-in-part Petitioners Motion for Additional Discovery 37.F.R sec. 42.51(b)(2), 42.52(a)

May 31, 2017PAPERBOARD

Order on Patent Owner Motion for Pro Hac Vice Admission of Jonathan Singer

May 31, 2017PAPERBOARD

Petitioner Mylan Pharmaceuticals Inc.¿¿¿s Mandatory Change-of-Information Notices

May 31, 2017PAPERPETITIONER

Patent Owner's Opposition to Motion for Discovery

May 23, 2017PAPERPATENT OWNER

Memorandum Opinion and Order

May 23, 2017EXHIBITPATENT OWNER

Petitioner¿¿¿s Notice of Deposition of Rhett M. Schiffman, M.D

May 22, 2017PAPERPETITIONER

Petitioner's Notice of Deposition of Robert S. Maness, Ph.D

May 22, 2017PAPERPETITIONER

Petitioner¿¿¿s Notice of Deposition of Thorsteinn Loftsson, Ph.D

May 22, 2017PAPERPETITIONER

Petitioner's Motion for Discovery

May 18, 2017PAPERPETITIONER

Order - re Authorization to file Motion for Additional Discovery and Opposition to Motion for Additional Discovery

May 16, 2017PAPERBOARD

Patent Owner's Notice of Designation of Additional Back-Up Counsel

May 3, 2017PAPERPATENT OWNER

Patent Owner's Motion for PHV Admission

May 2, 2017PAPERPATENT OWNER

Declaration of Jonathan Singer in Support of Motion for PHV Admission

May 2, 2017EXHIBITPATENT OWNER

Decision - 37 C.F.R. 42.108; 37 C.F.R. 42.122(b)

Mar 31, 2017PAPERBOARD

COPY ONLY of Order from Terminated IPR2017-00601 Granting Joinder with IPR2016-01132

Mar 31, 2017PAPERBOARD

Exhibit 3001

Mar 31, 2017EXHIBITBOARD

Petitioner Mylan Pharmaceuticals Inc.'s Notice of Objection to Evidence

Mar 27, 2017PAPERPETITIONER

Patent Owner's Response

Mar 20, 2017PAPERPATENT OWNER

Agarwal, Priyanka and Ilva D. Rupenthal, "Modern Approaches to the Ocular Delivery of Cyclosporine A"

Mar 20, 2017EXHIBITPATENT OWNER

Higuchi, "Physical Chemical Analysis of Percutaneous Absorption Process From Creams and Ointments"

Mar 20, 2017EXHIBITPATENT OWNER

Lallemand et al., "Cyclosporine a Delivery to the Eye: A Pharmaceutical Challenge"

Mar 20, 2017EXHIBITPATENT OWNER

Damato et al., "Senile Atrophy of the Human Lacrimal Gland: The Contribution of Chronic Inflammatory Disease"

Mar 20, 2017EXHIBITPATENT OWNER

das Neves et al., Mucosal Delivery of Biopharmaceuticals: Biology, Challenges and Strategies

Mar 20, 2017EXHIBITPATENT OWNER

Power et al., Effect of Topical Cyclosporin A on Conjunctival T Cells in Patients with Secondary Sj¿¿gren¿¿¿s Syndrome

Mar 20, 2017EXHIBITPATENT OWNER

Schaefer et al., Skin Permeability, Springer-Verlag (1982)

Mar 20, 2017EXHIBITPATENT OWNER

Williamson et al., Histology of the Lacrimal Gland in Keratoconjunctivitis Sicca, Brit. F. Ophthal /91973)

Mar 20, 2017EXHIBITPATENT OWNER

Approved Drug Products with Therapeutic Equivalence Evaluations, U.S. Department of Health and Huma Services, 37th Edition (2017)

Mar 20, 2017EXHIBITPATENT OWNER

Lemp, Michael A., Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes, CLAO Journal, vol. 21, no. 4 (October 1995), Part 2 of 2

Mar 20, 2017EXHIBITPATENT OWNER

Deposition transcript of Mansoor Amiji, Ph.D

Mar 20, 2017EXHIBITPATENT OWNER

Declaration of John D. Sheppard, M.D., M.M.Sc.

Mar 20, 2017EXHIBITPATENT OWNER

Stern et al., The Pathology of Dry Eye: The Interaction Between the Ocular Surface and Lacrimal Glands, Cornea 17(6): 584-589 (1998)

Mar 20, 2017EXHIBITPATENT OWNER

Wepierre, Jacques and Jean-Paul Marty, Percutaneous Absorption of Drugs, Elsvier/North-Holland Biomedical Press (1970)

Mar 20, 2017EXHIBITPATENT OWNER

Lemp, Michael A., Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes, CLAO Journal, vol. 21, no. 4 (October 1995), Part 1 of 2

Mar 20, 2017EXHIBITPATENT OWNER

Declaration of Dr. Thorsteinn Loftsson, Ph.D.

Mar 20, 2017EXHIBITPATENT OWNER

Declaration of Eric Rubinson

Mar 20, 2017EXHIBITPATENT OWNER

DiMasi, Risks in New Drug Development: Approval Success Rates for Investigational Drugs, Clinical Pharmacology and Therapeutics, May 2001

Mar 20, 2017EXHIBITPATENT OWNER

Facts About Dry Eye, https://nei.nih.gov/health/dryeye/dryeye

Mar 20, 2017EXHIBITPATENT OWNER

Allergan PK-98-074 Report

Mar 20, 2017EXHIBITPATENT OWNER

FDA Review, The Drug Development and Approval Process

Mar 20, 2017EXHIBITPATENT OWNER

Allergan ¿¿¿ NYSE: AGN ¿¿¿ Company Profile

Mar 20, 2017EXHIBITPATENT OWNER

Drugs@FDA: FDA Approved Drug Products, http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021023

Mar 20, 2017EXHIBITPATENT OWNER

Drugs@FDA: FDA Approved Drug Products, Restasis Approved, http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-023_Restasis_Approv.PDF

Mar 20, 2017EXHIBITPATENT OWNER

Drugs@FDA: FDA Approved Drug Products, http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050790

Mar 20, 2017EXHIBITPATENT OWNER

Christopher Glenn, New Thinking Spurs New Products, Review of Ophthalmology, February 15, 2003

Mar 20, 2017EXHIBITPATENT OWNER

Joan-Marie Stiglich ELS, Restasis: the road to approval, Ocular Surgery News, March 1, 2003

Mar 20, 2017EXHIBITPATENT OWNER

FDA label for Xiidra

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Inc., Credit Suisse First Boston Equity Research Report, Jan 30, 2003

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Inc., Buckingham Research Group Equity Research Report, Feb 5, 2003

Mar 20, 2017EXHIBITPATENT OWNER

Mark B. Abelson, MD and Jason Casavant, Give Dry Eye a One-two Punch, Review of Ophthalmology, March 15, 2003

Mar 20, 2017EXHIBITPATENT OWNER

Lynda Charters, Increased Tear Production, Ophthalmology Times, February 1, 2003

Mar 20, 2017EXHIBITPATENT OWNER

Jonathan R. Pirnazar, MD, Taking a Custom Approach to Dry Eye Treatment, Ophthalmology Management, February 1, 2004

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Inc., JP Morgan Equity Research Report, Nov 1, 2005

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Inc. (AGN) - Q4 2002 Financial Release Conference Call Wednesday, January 29, 2003 11:00 am Fair Disclosure Financial Network

Mar 20, 2017EXHIBITPATENT OWNER

Sales-Units_2011-2016_AllData_NSP_Feb-19-2017_RESTASIS.xlsx

Mar 20, 2017EXHIBITPATENT OWNER

Iazuka and Jin, The Effect of Prescription Drug Advertising on Doctor Visits, Journal of Economics and Management Strategy, 2007

Mar 20, 2017EXHIBITPATENT OWNER

Bradford, Kleit, Nietert, et al, Effects of Direct-to-Consumer Advertising of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors or Attainment of LDL-C Goals, Clinical Therapeutics, 2006

Mar 20, 2017EXHIBITPATENT OWNER

Refresh Endura Lubricant Eye Drops (Allergan), Theodora

Mar 20, 2017EXHIBITPATENT OWNER

Patent Owner's Motion to Seal

Mar 20, 2017PAPERPATENT OWNER

Restasis P&L (US Only excl. Canada and Puerto Rico)

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Inc., SalomonSmithBarney Equity Research Report, Feb 12, 2003

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Inc., Morgan Stanley Equity Research Report, Jan 30, 2003

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Inc., Morgan Stanley Equity Research Report, Apr 30, 2004

Mar 20, 2017EXHIBITPATENT OWNER

Bradford, Kleit, Nietert, et al, How Direct-to-Consumer Television Advertising for Osteoarthritis Drugs Affect Physicians¿¿¿ Prescribing Behavior, Health Affairs, 2006

Mar 20, 2017EXHIBITPATENT OWNER

Calfee, Winston, and Stempski, Direct-to-Consumer Advertising and the Demand for Cholesterol Reducing Drugs, Journal of Law and Economics, 2002

Mar 20, 2017EXHIBITPATENT OWNER

Declaration of Robert S. Maness, Ph.D.

Mar 20, 2017EXHIBITPATENT OWNER

Deposition of David LeCause, February 17, 2017

Mar 20, 2017EXHIBITPATENT OWNER

Restasis Strategic Plan Forecast 2009-2013

Mar 20, 2017EXHIBITPATENT OWNER

commercial Restasis Formulary June 2006.xls

Mar 20, 2017EXHIBITPATENT OWNER

NOVEMBER 2006 input MHC Report Restasis Playbook data.ppt

Mar 20, 2017EXHIBITPATENT OWNER

Restasis Launch Marketing Plan, dated February 12-13, 2003

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Eye Care, US Dry Eye Strat Plan Narrative: Summary Version, April 16, 2011

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Dry Eye, Restasis Business Update, August 16, 2010

Mar 20, 2017EXHIBITPATENT OWNER

Restasis 2013 Managed Markets Tactics & Preliminary Budget, August 8, 2012

Mar 20, 2017EXHIBITPATENT OWNER

Allergan Dry Eye, Dry Eye Franchise 2014 Business Plan, 2014 U.S. Eye Care Sales & Marketing Plan, September 9, 2013

Mar 20, 2017EXHIBITPATENT OWNER

Kline, Kate, Restasis Professional Critical Issues, Allergan Dry Eye, 2010

Mar 20, 2017EXHIBITPATENT OWNER

Restasis NPA Monthly

Mar 20, 2017EXHIBITPATENT OWNER

Restasis Projects, Global R&D Cost

Mar 20, 2017EXHIBITPATENT OWNER

Patent Owner's Notice of Designation of Additional Back-Up Counsel

Feb 21, 2017PAPERPATENT OWNER

Notice of Joint Stipulation to Modify Due Dates 1, 2, and 4

Feb 10, 2017PAPERPATENT OWNER

Patent Owner's Notice of Deposition of Mansoor Amiji, Ph.D.

Feb 7, 2017PAPERPATENT OWNER

Petitioner Mylan Pharmaceuticals Inc.'s Notice of Objection to Evidence

Dec 22, 2016PAPERPETITIONER

Decision Institution of Inter Partes Review

Dec 8, 2016PAPERBOARD

Standing Order

Dec 8, 2016PAPERBOARD

Scheduling Order

Dec 8, 2016PAPERBOARD

NDA 21-023 Cyclosporine Ophthalmic Emulsion 0.05 - Part 2

Sep 9, 2016EXHIBITPATENT OWNER

NDA 21-023 Cyclosporine Ophthalmic Emulsion 0.05 - Part 1

Sep 9, 2016EXHIBITPATENT OWNER

Stedmans Medical Dictionary

Sep 9, 2016EXHIBITPATENT OWNER

U.S. Pat. No. 4,839,342

Sep 9, 2016EXHIBITPATENT OWNER

Investigative Ophthalmology & Visual Science

Sep 9, 2016EXHIBITPATENT OWNER

Folia Ophthalmol

Sep 9, 2016EXHIBITPATENT OWNER

RESTASIS label

Sep 9, 2016EXHIBITPATENT OWNER

Patent Owner's Preliminary Response

Sep 9, 2016PAPERPATENT OWNER

Dorlands Illustrated Medical Dictionary

Sep 9, 2016EXHIBITPATENT OWNER

Stedmans Medical Dictionary

Sep 9, 2016EXHIBITPATENT OWNER

The Once and Future Treatment of Dry Eye

Sep 9, 2016EXHIBITPATENT OWNER

Power of Attorney

Jun 27, 2016PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Related Matters

Jun 27, 2016PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Notice of Filing Date Accorded to Petition and Time for Filing Patent Owner Preliminary Response

Jun 9, 2016PAPERBOARD

Related Matters

Jun 3, 2016PAPERPETITIONER

Power of Attorney

Jun 3, 2016PAPERPETITIONER

IPR2016-01132 - Petition for Inter Partes Review of U.S. 9,248,191

Jun 3, 2016PAPERPETITIONER

Exhibit 1001 - U.S. 9,248,191 to Acheampong et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1002 - Declaration of Mansoor Amiji, Ph.D

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1003 - Curriculum Vitae of Manssor Amiji

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1004 - File History of U.S. Patent No. 9,248,191 Part 1 of 5

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1004 - File History of U.S. Patent No. 9,248,191 Part 2 of 5

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1004 - File History of U.S. Patent No. 9,248,191 Part 3 of 5

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1004 - File History of U.S. Patent No. 9,248,191 Part 4 of 5

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1004 - File History of U.S. Patent No. 9,248,191 Part 5 of 5

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1005 - File History of U.S. Patent Application No. 10927857 - Part 1 of 3

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1005 - File History of U.S. Patent Application No. 10927857 - Part 2 of 3

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1005 - File History of U.S. Patent Application No. 10927857 - Part 3 of 3

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1006 - U.S. 5,474,979 to Ding et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1007 - Sall et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1008 - Acheampong et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1009 - U.S. 5,578,586 to Glonek et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1010 - U.S. 5,981,607 to Ding et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1011 - Kaswan

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1012 - Kunert et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1013 - Physician's Desk Refernce for Ophthalmic Medicines

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1014 - Turner et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1015 - Stevenson et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1016 - Remington's 20th Edition

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1017 - Goto et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1018 - Kanpolat et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1019 - Vieira et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1020 - Murphy

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1021 - Small et al.

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1022 - Stedman's

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1023 - File History of U.S. Patent No. 8,685,930

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1024 - File History of U.S. Patent No. 8,629,111 Part 1 of 4

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1024 - File History of U.S. Patent No. 8,629,111 Part 2 of 4

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1024 - File History of U.S. Patent No. 8,629,111 Part 3 of 4

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1024 - File History of U.S. Patent No. 8,629,111 Part 4 of 4

Jun 3, 2016EXHIBITPETITIONER

Exhibit 1025 - Amended Complaint in 15-cv-01455

Jun 3, 2016EXHIBITPETITIONER